Deep Knowledge Group
Swiss Longevity Events, November 2021

From 21-26 November 2021, several Deep Knowledge Group' Partners and Senior Executives visited Switzerland (Geneva, Zurich and Basel) to host a number of invitation-only Longevity Finance and Investment events, and to engage key Swiss stakeholders (government officials industry professionals) on the prospects for transforming Switzerland into the world’s leading full-scope Longevity Finance, Industry, Biomedicine and Policy Hub (Swiss Longevity Valley).

 

The Deep Knowledge Group team in attendance for the events included: 

  • Deep Knowledge Group General Partner, Dmitry Kaminskiy

  • Managing Partner Stefan Hascoet (who also leads Deep Knowledge Ventures Swiss,  Deep Knowledge financial branch, located in Geneva)

  • Managing Partner, Dr. Sanja Baumann-Tomovska (a Basel-based precision medicine professional with 10+ years experience as a Department Head at Roche, Novartis & Abbott Life Sciences)

  • Director of Structured Products, Remus Stanescu (who also leads Deep Knowledge Group’s UK-based financial branch, Longevity Financial Advisors, located in London)

  • Partner and Director of Deep Knowledge Analytics and GovTech Analytics, Alex Cresniov

  • Deputy General Partner, Head of Investment Analytics, Ihor Kendiukhov

  • Vice President of Business Development and Investor Relations, Anastasia Lit

 

Deep Knowledge Group has been prioritizing its activities in Switzerland at the intersection of Longevity Finance, Investment, Industrialization and Policy for many years now to analyze the country's unique strengths and synergies in the spheres of Biomedicine, Precision Medicine, International Policy, Financial Industry, and Advanced AI-Empowered InvestTech Solutions to constitute an ideal foundation that could be leveraged to develop Switzerland into a world-leading full-scope Longevity Valley.

Investing in Longevity Event in Geneva, Switzerland

 

On 23 November 2021 Deep Knowledge Group hosted an invitation-only Longevity Event in Geneva: ‘INVESTING IN LONGEVITY’


The event covered several important topics, including:

  • ​Investing into the Largest Wealth Creation Opportunity of The Decade

  • Private Equity, Venture Capital, Public Markets

  • De-Risking and Optimization of Investments

  • Practical Human Longevity

  • Hype vs Reality

 
Screenshot 2021-12-14 at 15.59.37.png

Deep Knowledge Group General Partner Dmitry Kaminskiy delivered a presentation entitled Longevity Industry Overview 2021-2022 and Longevity Investments De-Risking / Longevity Finance, alongside a presentation on Private Equity & Venture, Longevity Assets and Financial Products by Deep Knowledge Group Managing Partner Stefan Hascoet, who also leads Deep Knowledge Ventures Swiss, a Geneva-based financial arm of Deep Knowledge Group devoted to the development of structured financial products and derivatives in Switzerland, as well as to conduct various kinds of financial and investment activities in DeepTech industries.

E356CBB7-3BA2-43A4-964B-01E7949DB5C1.heic
fd368c88-e511-439c-a989-92ca7e239504_720.png

Four Seasons Hotel, Geneva, Switzerland

During the event, the Deep Knowledge Group team witnessed strong interest in the Longevity Industry from a number of investors, financial executives, and industry professionals in attendance, with whom we spoke about the future perspectives of the industry. 

 

Dmitry Kaminskiy also delivered a presentation of his series of published and upcoming Longevity Books, including Longevity Industry 1.0: Defining the Biggest and Most Complex Industry in Human History, Longevity Financial Industry: Health as the New Wealth, Longevity FinTech, WealthTech, InvestTech, InsurTech, AgeTech, and the Coming Rise of Longevity Banks, Investment Banks, Stock Exchanges, ETFs, Indices, and Novel Financial Instruments and Derivatives, and Longevity Industry 2.0: DeepTech Engineering the Accelerated Trajectory of Human Longevity: The Blueprint and Pathway from Longevity Industry 1.0 to 2.0, but with major emphasis on his newest book, Biomarkers of Human Longevity: Data Science for Accelerating Aging Research and R&D and The Critical Catalyst for Practical Human Longevity, Tangible Investment Decision Making and De-Risking’, to the audience.

Biomarkers of Human Longevity with shadow.png
3.png
Screenshot 2021-12-09 at 17.02.36.png

Investing in Longevity Event in Zurich, Switzerland
 

The following day, on 24 November 2021, a parallel 'INVESTING IN LONGEVITY' private event was hosted by Deep Knowledge Group in Zurich, Switzerland. 

 
IMG_conference (3)_edited_edited.jpg
IMG_4184_Books (1).png

Zunfthaus zur Zimmerleuten, Zürich, Switzerland

Deep Knowledge Group General Partner Dmitry Kaminskiy delivered a presentation entitled Longevity Industry Overview 2021-2022 and Longevity Investments De-Risking / Longevity Finance, alongside a talk by Remus Stanescu, Director of Structured Products at Deep Knowledge Group’s UK-based financial branch, Longevity Financial Advisors, which provided an Overview of Deep Knowledge Group Financial Activities.